Mutations in the gene responsible for malignant hyperthermia
Fujii, J.; Otsu, K.
Seikagaku. Journal of Japanese Biochemical Society 64(9): 1129-1133
1992
ISSN/ISBN: 0037-1017 PMID: 1460346 Document Number: 394546
Document emailed within 1 workday
Related Documents
Sambuughin, N.; Sei, Y.; Gallagher, K.L.; Wyre, H.W.; Madsen, D.; Nelson, T.E.; Fletcher, J.E.; Rosenberg, H.; Muldoon, S.M. 2001: North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations Anesthesiology 95(3): 594-599Liu, Y.-h.; Ke, X.-m.; Xiao, S.-f. 2005: Heterogeneous mutations of Wolfram syndrome i gene responsible for low frequency nonsyndromic hearing loss Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 40(10): 764-768
Kowalska, A. 2003: Amyloid precursor protein gene mutations responsible for early-onset autosomal dominant Alzheimer's disease Folia Neuropathologica 41(1): 35-40
Larach, M.G.; Landis, J.R.; Bunn, J.S.; Diaz, M. 1992: Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry Anesthesiology 76(1): 16-27
Ayan, I.; Luca, J.W.; Jaffe, N.; Yazici, H.; Ekmekçioğlu, S.; Hansen, M.F. 1998: Germline mutations of the p53 gene in children with malignant solid tumors Journal of Experimental and Clinical Cancer Research: Cr 17(4): 497-502
Ichihara, Y.; Sasaki, J.; Kikuchi, H.; Ozawa, M.; Goto, Y.; Nonaka, I. 2000: Preliminary report: first identification of known mutation in the ryanodine receptor gene in a Japanese malignant hyperthermia pedigree Masui. Japanese Journal of Anesthesiology 49(4): 404-406
Mihic-Probst, D.; Perren, A.; Schmid, S.; Saremaslani, P.; Komminoth, P.; Heitz, P.U. 2004: Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma Anticancer Research 24(4): 2415-2418
Akaike, M.; Kawai, H. 1997: Gene analysis in patients with muscular dystrophy: alpha-sarcoglycan (adhalin) gene mutations in patients with malignant limb-girdle muscular dystrophy Rinsho Byori. Japanese Journal of Clinical Pathology 45(2): 136-140
de Serres, F.J.; Overton, L.K.; Sadler, B.M. 1992: X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. XI. Heterozygous effects of gene/point mutations of genotype ad-3A or ad-3B Mutation Research 269(1): 149-169
Khalizev, A.E.; Pyzhov, A.P.; Shapiro, N.I. 1976: Development of spontaneous mutations in somatic mamalian cells and DNA replication. II. Expression of gene mutations in cultured cells Genetika 12(11): 51-60
Katabuchi, H.; van Rees, B.; Lambers, A.R.; Ronnett, B.M.; Blazes, M.S.; Leach, F.S.; Cho, K.R.; Hedrick, L. 1995: Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas Cancer Research 55(23): 5556-5560
Van Woerden, C.S.; Groothof, J.W.; Wanders, R.J.A.; Waterham, H.R.; Wijburg, F.R. 2006: From gene to disease; primary hyperoxaluria type i caused by mutations in the AGXT gene Nederlands Tijdschrift Voor Geneeskunde 150(30): 1669-1672
Witzel-Schlömp, K.; Späth, P.J.; Hobart, M.J.; Fernie, B.A.; Rittner, C.; Kaufmann, T.; Schneider, P.M. 1997: The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure Journal of Immunology 158(10): 5043-5049
Fehmann, H.C.; Göke, B. 1994: One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma Zeitschrift für Gastroenterologie 32(7): 416-417
De Haan, G.J.; Halley, D.J.J.; Deelen, W.H.; Lindhout, D. 2002: From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene Nederlands Tijdschrift Voor Geneeskunde 146(18): 846-848
Cornelissen, E.A.M.; Bindels, R.J.M.; Hoefsloot, L.H.; Knoers, N.V.A.M. 2005: From gene to disease; mutations in the SLC12A3 gene as the cause of Gitelman's syndrome Nederlands Tijdschrift Voor Geneeskunde 149(24): 1330-1333
Mouroux, M.; Descamps, D.; Izopet, J.; Yvon, A.; Delaugerre, C.; Matheron, S.; Coutellier, A.; Valantin, M.A.; Bonmarchand, M.; Agut, H.; Massip, P.; Costagliola, D.; Katlama, C.; Brun-Vezinet, F.; Calvez, V. 2001: Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy Antiviral Therapy 6(3): 179-183
Jessop, A.P.; Glansdorff, N. 1980: Genetic factors affecting recovery of nonpoint mutations in the region of a gene coding for ornithine transcarbamylase: involvement of both the F factor in its chromosomal state and the recA gene Genetics 96(4): 779-799
Von Ardenne, M.; Reitnauer, P.G. 1971: In vitro study for shortening of hyperthermia duration in multi-step cancer therapy. Release of lysosomal cytolysis chain reaction by over-acidification and hyperthermia and its continuation after cessation of hyperthermia Archiv für Geschwulstforschung 38(3): 264-269
Ichihara, Y.; Kikuchi, H. 2012: Malignant hyperthermia Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 681-685